Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies
Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engi...
Saved in:
Published in | Pharmaceutical research Vol. 35; no. 11; pp. 220 - 12 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.11.2018
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs.
Methods
Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [
13
C-
1
H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments.
Results
Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution.
Conclusion
The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. |
---|---|
AbstractList | Purpose
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs.
Methods
Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [
13
C-
1
H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments.
Results
Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution.
Conclusion
The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. PurposeFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs.MethodsHere, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [13C-1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments.ResultsUnlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution.ConclusionThe overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [ C- H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [.sup.13C-.sup.1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Methods Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [.sup.13C-.sup.1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Results Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. Conclusion The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs. |
ArticleNumber | 220 |
Audience | Academic |
Author | Alphonse Ignatius, Arun Kimmel, Michael Majumder, Subhabrata Jones, Michael T. |
Author_xml | – sequence: 1 givenname: Subhabrata surname: Majumder fullname: Majumder, Subhabrata organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc – sequence: 2 givenname: Michael T. surname: Jones fullname: Jones, Michael T. organization: Analytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc – sequence: 3 givenname: Michael surname: Kimmel fullname: Kimmel, Michael organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc – sequence: 4 givenname: Arun orcidid: 0000-0002-7342-044X surname: Alphonse Ignatius fullname: Alphonse Ignatius, Arun email: arun.alphonseignatius@pfizer.com organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30255351$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1rFTEUxYNU7Gv1D3AjA27cTL03k8zH8vFqW6GiCwVdhUzmZkiZSWoyT-h_b16nfqJkEUh-53DvOSfsyAdPjD1HOEOA5nVChE6WgG3JJUDZPmIblE1VdiA-H7ENNFyUbSPwmJ2kdAMALXbiCTuugEtZSdywLx9i6J0fi13wNsRZLy54PRXn7hvF5Ja7ItjiwhTnYdbOp8L5YjuOkcZ7sMxqT8W74IOZ7nVbv7g-DI7SU_bY6inRs4f7lH26ePNxd1Vev798u9tel0aCXEouOrIAvCFtBDTV0KIYtBC10b2mjovBNAB1jS3ZrtYotbFkhWhsy83Q8-qUvVp9b2P4uqe0qNklQ9OkPYV9UhyR11hx2WX05V_oTdjHPPZKgch5_UaNeiLlcixL1OZgqrYZ4AhYQabO_kHlM9DsTE7Fuvz-hwBXgYkhpUhW3UY363inENShTrXWqXKd6lCnarPmxcPA-36m4afiR38Z4CuQ8pcfKf7a6P-u3wFIQqos |
CitedBy_id | crossref_primary_10_1016_j_addr_2021_02_007 crossref_primary_10_1021_acs_analchem_9b05385 crossref_primary_10_1016_j_xphs_2022_06_014 crossref_primary_10_3389_fbioe_2023_1257665 crossref_primary_10_3390_antib8020036 crossref_primary_10_1007_s11095_022_03200_6 crossref_primary_10_1016_j_xphs_2019_10_038 crossref_primary_10_1007_s11095_019_2652_1 crossref_primary_10_1093_glycob_cwz068 |
Cites_doi | 10.1021/bi026364g 10.1021/bi702238b 10.1021/bi002898a 10.1021/ac802575y 10.1002/pro.362 10.1016/j.tibs.2009.07.004 10.1002/jps.21104 10.1016/j.febslet.2014.01.051 10.4161/19420862.2014.985494 10.1016/j.jmr.2014.01.008 10.1002/bip.360311007 10.1021/mp500005v 10.1002/jps.23056 10.1016/j.tibtech.2014.05.005 10.1021/bi00447a048 10.1006/jmbi.1998.2556 10.1021/ci700237g 10.1021/mp400666b 10.1016/j.xphs.2017.02.007 10.1038/385787a0 10.4161/mabs.23532 10.1016/j.bbrc.2007.02.042 10.1021/ac504804m 10.1126/science.1184991 10.1007/s12104-014-9586-7 10.1126/science.1124964 10.1002/jps.23543 10.1016/j.xphs.2017.10.010 10.1021/jacs.8b00931 10.1016/S0006-3495(00)76462-9 10.1021/ja300265w 10.1021/ja072157y 10.1038/nri2747 10.1002/pro.2340 10.1021/ac404130a 10.1021/acs.analchem.7b03571 10.4049/jimmunol.1401218 10.1002/jps.23827 10.1007/s11095-015-1802-3 10.1016/0014-5793(81)80642-4 10.1073/pnas.97.15.8340 10.1093/jb/mvt095 10.1038/nrd3229 10.1038/srep32201 10.1073/pnas.1305688110 10.1016/j.molimm.2013.03.018 10.1016/j.jbiosc.2011.06.017 10.1016/S0006-3495(00)76602-1 10.1016/j.xphs.2017.08.011 10.1002/jps.21514 10.1021/ja00381a009 10.1038/nature01891 10.1021/bi00527a016 10.1016/S0022-2836(02)01250-0 10.1021/bi400232p 10.1002/biot.201000091 10.1021/mp200404c 10.1002/jps.21269 10.1016/j.molimm.2009.01.026 10.1002/pro.396 10.1016/j.str.2018.03.017 10.1080/19420862.2016.1269580 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2018 COPYRIGHT 2018 Springer Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2018 – notice: COPYRIGHT 2018 Springer – notice: Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved. |
DBID | NPM AAYXX CITATION 3V. 7RV 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s11095-018-2500-8 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Neurosciences Abstracts Proquest Health & Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Eastern Edition PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: ProQuest_Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1573-904X |
EndPage | 12 |
ExternalDocumentID | A724210130 10_1007_s11095_018_2500_8 30255351 |
Genre | Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29O 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYOK AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOAH ADOXG ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFDYV AFEXP AFGCZ AFKRA AFLOW AFNRJ AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AOSHJ ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IJ- IKXTQ IMOTQ INH ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAK LLZTM LSO M1P M4Y MA- MK0 N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 WOW YCJ YLTOR Z45 Z5O Z7S Z7U Z7V Z7W Z7X Z81 Z82 Z83 Z84 Z87 Z88 Z8N Z8O Z8P Z8Q Z8R Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ~KM AACDK AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV H13 NPM AAEOY AAQLM AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c505t-249ef0027eac4073d814da446cabae924dc7006618ef96a15acfef447f82cdb23 |
IEDL.DBID | U2A |
ISSN | 0724-8741 |
IngestDate | Fri Oct 25 03:15:09 EDT 2024 Wed Nov 06 08:28:51 EST 2024 Thu Feb 22 23:52:20 EST 2024 Tue Nov 12 23:30:56 EST 2024 Fri Sep 13 09:29:02 EDT 2024 Wed Oct 16 00:59:35 EDT 2024 Sat Dec 16 11:59:17 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Fc domain differential scanning calorimetry nuclear magnetic resonance spectroscopy storage stability aggregation Fab domain molecular fingerprinting monoclonal antibodies |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c505t-249ef0027eac4073d814da446cabae924dc7006618ef96a15acfef447f82cdb23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7342-044X |
PMID | 30255351 |
PQID | 2112047249 |
PQPubID | 37334 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2112613259 proquest_journals_2112047249 gale_infotracmisc_A724210130 gale_infotracacademiconefile_A724210130 crossref_primary_10_1007_s11095_018_2500_8 pubmed_primary_30255351 springer_journals_10_1007_s11095_018_2500_8 |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationSubtitle | An Official Journal of the American Association of Pharmaceutical Scientists |
PublicationTitle | Pharmaceutical research |
PublicationTitleAbbrev | Pharm Res |
PublicationTitleAlternate | Pharm Res |
PublicationYear | 2018 |
Publisher | Springer US Springer Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer – name: Springer Nature B.V |
References | Teplyakov, Zhao, Malia, Obmolova, Gilliland (CR31) 2013; 56 Manikwar, Majumdar, Hickey, Thakkar, Samra, Sathish, Volkin (CR18) 2013; 102 Zhang, Hu, MacGregor, Xue, Fan, Suchecki, Liu (CR15) 2014; 86 Palmer (CR36) 2014; 241 Arbogast, Delaglio, Schiel, Marino (CR21) 2017; 89 Liu, Ren, Huang, Dankberg, Rosenfeld, Cocco (CR41) 2008; 47 Iwura, Fukuda, Yamazaki, Kanamaru, Arisaka (CR63) 2013; 155 Grevys (CR4) 2015; 194 Rose, van Berkel, van den Bremer, Labrijn, Vink, Schuurman, Parren (CR14) 2013; 5 Mittermaier, Kay (CR42) 2006; 312 Arbogast, Brinson, Formolo, Hoopes, Marino (CR22) 2016; 33 Arora, Joshi, Middaugh, Weis, Volkin (CR65) 2017; 106 Kjellsson, Sethson, Jonsson (CR57) 2003; 42 Houde, Arndt, Domeier, Berkowitz, Engen (CR13) 2009; 81 Arbogast, Brinson, Marino (CR20) 2015; 87 Hanson, Yguerabide, Schumaker (CR33) 1981; 20 Ionescu, Vlasak, Price, Kirchmeier (CR25) 2008; 97 Singh, Bandi, Jones, Mallela (CR29) 2017; 106 Teplyakov, Zhao, Malia, Obmolova, Gilliland (CR46) 2013; 56 Roberts (CR54) 2014; 32 Burkitt, Domann, O'connor (CR16) 2010; 19 Folch, Rooman, Dehouck (CR51) 2008; 48 CR3 Robustelli, Stafford, Palmer (CR35) 2012; 134 Krapp, Mimura, Jefferis, Huber, Sondermann (CR39) 2003; 325 Garber, Demarest (CR24) 2007; 355 Samra, He (CR5) 2012; 9 Moorthy, Schultz, Kim, Topp (CR49) 2014; 11 Majumdar, Manikwar, Hickey, Samra, Sathish, Bishop, Weis (CR17) 2013; 52 Dolgikh, Gilmanshin, Brazhnikov, Bychkova, Semisotnov, Venyaminov, Ptitsyn (CR58) 1981; 136 Brader, Estey, Bai, Alston, Lucas, Lantz (CR64) 2015; 12 Vermeer, Norde, van Amerongen (CR30) 2000; 79 Yagi, Zhang, Yagi-Utsumi, Yamaguchi, Iida, Yamaguchi, Kato (CR44) 2015; 9 Kamerzell, Middaugh (CR10) 2008; 97 Brandts, Hu, Lin, Mas (CR27) 1989; 28 Pace, Joshi, Esfandiary, Stadelman, Bishop, Middaugh (CR60) 2018; 107 Van Buren, Rehder, Gadgil, Matsumura, Jacob (CR55) 2009; 98 Mittermaier, Kay (CR47) 2009; 12 Chiti, Stefani, Taddei, Ramponi, Dobson (CR62) 2003; 424 Beck (CR1) 2010; 10 Nelson, Dhimolea, Reichert (CR2) 2010; 9 Calzolai, Lysek, Güntert, von Schroetter, Riek, Zahn, Wüthrich (CR59) 2000; 97 Kitevski-LeBlanc, Yuwen, Dyer, Rudolph, Luger, Kay (CR43) 2018; 140 Mittermaier, Kay (CR37) 2009; 34 Religa, Sprangers, Kay (CR45) 2010; 328 Tischenko, ZaVyalov, Medgyesi, Potekhin, Privalov (CR26) 1982; 3 Booth, Sunde, Bellotti, Robinson (CR56) 1997; 385 CR52 Nishi, Miyajima, Wakiyama, Kubota, Hasegawa, Uchiyama, Fukui (CR7) 2011; 112 Menzen, Friess (CR6) 2014; 103 Japelj, Ilc, Marušič, Senčar, Kuzman, Plavec (CR23) 2016; 6 Ito, Tsumoto (CR50) 2013; 22 Lipari, Szabo (CR38) 1982; 104 Kessler, Mronga, Müller, Moroder, Huber (CR32) 1991; 31 Viles, Donne, Kroon, Prusiner, Cohen, Dyson, Wright (CR48) 2001; 40 Wu, Kroe-Barrett, Singh, Robinson, Roberts (CR53) 2014; 588 Sekhar, Kay (CR19) 2013; 110 Kayser, Chennamsetty, Voynov, Forrer, Helk, Trout (CR40) 2010; 6 Majumdar, Esfandiary, Bishop, Samra, Middaugh, Volkin, Weis (CR8) 2015; 7 Abedini, Meng, Raleigh (CR61) 2007; 129 Boehm, Woof, Kerr, Perkins (CR34) 1999; 286 Vermeer, Norde (CR11) 2000; 78 Oganesyan, Damschroder, Woods, Cook, Wu, Dall’Acqua (CR9) 2009; 46 Chen, Brodsky, Kleemann, Latypov (CR12) 2010; 19 Sahin, Weiss, Kroetsch, King, Kessler, Das, Roberts (CR28) 2012; 101 25728213 - Anal Chem. 2015 Apr 7;87(7):3556-61 23594236 - Biochemistry. 2013 May 14;52(19):3376-89 29731233 - Structure. 2018 Jul 3;26(7):1007-1014.e2 1665090 - Biopolymers. 1991 Sep;31(10):1189-204 18161956 - J Chem Inf Model. 2008 Jan;48(1):119-27 23868852 - Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12867-74 23628091 - Mol Immunol. 2013 Nov;56(1-2):131-9 28843351 - J Pharm Sci. 2017 Dec;106(12):3486-3498 18680168 - J Pharm Sci. 2009 Sep;98(9):3013-30 25687223 - Mol Pharm. 2015 Apr 6;12(4):1005-17 9039909 - Nature. 1997 Feb 27;385(6619):787-93 10900000 - Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8340-5 24908382 - Trends Biotechnol. 2014 Jul;32(7):372-80 27578487 - Sci Rep. 2016 Aug 31;6:32201 24597564 - Anal Chem. 2014 Apr 1;86(7):3468-75 7140745 - Eur J Biochem. 1982 Sep 1;126(3):517-21 22246657 - J Pharm Sci. 2012 May;101(5):1678-87 16614210 - Science. 2006 Apr 14;312(5771):224-8 20414207 - Nat Rev Immunol. 2010 May;10(5):345-52 22263524 - Mol Pharm. 2012 Apr 2;9(4):696-707 25524268 - MAbs. 2015;7(1):84-95 18186490 - J Pharm Sci. 2008 Sep;97(9):3494-517 20811384 - Nat Rev Drug Discov. 2010 Oct;9(10):767-74 7317358 - Biochemistry. 1981 Nov 24;20(24):6842-52 25904551 - J Immunol. 2015 Jun 1;194(11):5497-508 19250681 - Mol Immunol. 2009 May;46(8-9):1750-5 10064707 - J Mol Biol. 1999 Mar 12;286(5):1421-47 20360109 - Science. 2010 Apr 2;328(5974):98-102 28212986 - J Pharm Sci. 2017 Jun;106(6):1508-1518 11023918 - Biophys J. 2000 Oct;79(4):2150-4 28937210 - Anal Chem. 2017 Nov 7;89(21):11839-11845 22381384 - J Am Chem Soc. 2012 Apr 11;134(14):6365-74 27960628 - MAbs. 2017 Feb/Mar;9(2):167-181 24530501 - FEBS Lett. 2014 Mar 18;588(6):936-41 12527303 - J Mol Biol. 2003 Jan 31;325(5):979-89 26453189 - Pharm Res. 2016 Feb;33(2):462-75 24155259 - J Biochem. 2014 Jan;155(1):63-71 23963869 - Protein Sci. 2013 Nov;22(11):1542-51 20162626 - Protein Sci. 2010 Apr;19(4):826-35 17321501 - Biochem Biophys Res Commun. 2007 Apr 13;355(3):751-7 11258885 - Biochemistry. 2001 Mar 6;40(9):2743-53 19265386 - Anal Chem. 2009 Apr 1;81(7):2644-51 25291979 - Biomol NMR Assign. 2015 Oct;9(2):257-60 21783411 - J Biosci Bioeng. 2011 Oct;112(4):326-32 17721938 - J Pharm Sci. 2008 Apr;97(4):1414-26 20512972 - Protein Sci. 2010 Jun;19(6):1191-204 20949542 - Biotechnol J. 2011 Jan;6(1):38-44 29037466 - J Pharm Sci. 2018 Feb;107(2):559-570 24816133 - Mol Pharm. 2014 Jun 2;11(6):1869-79 24382634 - J Pharm Sci. 2014 Feb;103(2):445-55 7327267 - FEBS Lett. 1981 Dec 28;136(2):311-5 17722920 - J Am Chem Soc. 2007 Sep 19;129(37):11300-1 10620303 - Biophys J. 2000 Jan;78(1):394-404 24656076 - J Magn Reson. 2014 Apr;241:3-17 12917692 - Nature. 2003 Aug 14;424(6950):805-8 18407665 - Biochemistry. 2008 May 6;47(18):5088-100 19846313 - Trends Biochem Sci. 2009 Dec;34(12):601-11 2690944 - Biochemistry. 1989 Oct 17;28(21):8588-96 23620222 - J Pharm Sci. 2013 Jul;102(7):2136-51 12525163 - Biochemistry. 2003 Jan 21;42(2):363-74 29589929 - J Am Chem Soc. 2018 Apr 11;140(14):4774-4777 23406897 - MAbs. 2013 Mar-Apr;5(2):219-28 H Kessler (2500_CR32) 1991; 31 AK Mittermaier (2500_CR47) 2009; 12 SM Singh (2500_CR29) 2017; 106 D Liu (2500_CR41) 2008; 47 Arnoldus W.P. Vermeer (2500_CR11) 2000; 78 A Teplyakov (2500_CR31) 2013; 56 SE Pace (2500_CR60) 2018; 107 A Kjellsson (2500_CR57) 2003; 42 A Teplyakov (2500_CR46) 2013; 56 AL Nelson (2500_CR2) 2010; 9 L Calzolai (2500_CR59) 2000; 97 T Menzen (2500_CR6) 2014; 103 LW Arbogast (2500_CR21) 2017; 89 A Sekhar (2500_CR19) 2013; 110 R Majumdar (2500_CR17) 2013; 52 R Majumdar (2500_CR8) 2015; 7 Veysel Kayser (2500_CR40) 2010; 6 JF Brandts (2500_CR27) 1989; 28 JL Kitevski-LeBlanc (2500_CR43) 2018; 140 MK Boehm (2500_CR34) 1999; 286 AW Vermeer (2500_CR30) 2000; 79 RM Ionescu (2500_CR25) 2008; 97 DR Booth (2500_CR56) 1997; 385 HS Samra (2500_CR5) 2012; 9 J Arora (2500_CR65) 2017; 106 2500_CR3 VM Tischenko (2500_CR26) 1982; 3 AK Mittermaier (2500_CR37) 2009; 34 CJ Roberts (2500_CR54) 2014; 32 A Grevys (2500_CR4) 2015; 194 V Oganesyan (2500_CR9) 2009; 46 F Chiti (2500_CR62) 2003; 424 G Lipari (2500_CR38) 1982; 104 B Folch (2500_CR51) 2008; 48 A Mittermaier (2500_CR42) 2006; 312 N Buren Van (2500_CR55) 2009; 98 LW Arbogast (2500_CR20) 2015; 87 W Burkitt (2500_CR16) 2010; 19 TL Religa (2500_CR45) 2010; 328 T Iwura (2500_CR63) 2013; 155 BS Moorthy (2500_CR49) 2014; 11 DA Dolgikh (2500_CR58) 1981; 136 TJ Kamerzell (2500_CR10) 2008; 97 H Nishi (2500_CR7) 2011; 112 A Beck (2500_CR1) 2010; 10 H Wu (2500_CR53) 2014; 588 B Japelj (2500_CR23) 2016; 6 AG Palmer III (2500_CR36) 2014; 241 2500_CR52 A Abedini (2500_CR61) 2007; 129 S Krapp (2500_CR39) 2003; 325 SLH Chen (2500_CR12) 2010; 19 E Sahin (2500_CR28) 2012; 101 D Houde (2500_CR13) 2009; 81 A Zhang (2500_CR15) 2014; 86 H Yagi (2500_CR44) 2015; 9 JH Viles (2500_CR48) 2001; 40 LW Arbogast (2500_CR22) 2016; 33 T Ito (2500_CR50) 2013; 22 ML Brader (2500_CR64) 2015; 12 P Manikwar (2500_CR18) 2013; 102 RJ Rose (2500_CR14) 2013; 5 DC Hanson (2500_CR33) 1981; 20 P Robustelli (2500_CR35) 2012; 134 E Garber (2500_CR24) 2007; 355 |
References_xml | – volume: 42 start-page: 2363 year: 2003 end-page: 2374 ident: CR57 article-title: Hydrogen exchange in a large 29 kD protein and characterization of molten globule aggregation by NMR publication-title: Biochemistry doi: 10.1021/bi026364g contributor: fullname: Jonsson – volume: 47 start-page: 5088 year: 2008 end-page: 5100 ident: CR41 article-title: Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation publication-title: Biochemistry doi: 10.1021/bi702238b contributor: fullname: Cocco – volume: 40 start-page: 2743 issue: 9 year: 2001 end-page: 2753 ident: CR48 article-title: Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics publication-title: Biochemistry doi: 10.1021/bi002898a contributor: fullname: Wright – volume: 81 start-page: 2644 issue: 7 year: 2009 end-page: 2651 ident: CR13 article-title: Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry publication-title: Anal Chem doi: 10.1021/ac802575y contributor: fullname: Engen – volume: 19 start-page: 826 issue: 4 year: 2010 end-page: 835 ident: CR16 article-title: Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometry publication-title: Protein Sci doi: 10.1002/pro.362 contributor: fullname: O'connor – volume: 12 start-page: 601 issue: 34 year: 2009 end-page: 611 ident: CR47 article-title: Observing biological dynamics at atomic resolution using NMR publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2009.07.004 contributor: fullname: Kay – volume: 97 start-page: 1414 issue: 4 year: 2008 end-page: 1426 ident: CR25 article-title: Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies publication-title: J Pharm Sci doi: 10.1002/jps.21104 contributor: fullname: Kirchmeier – volume: 588 start-page: 936 issue: 6 year: 2014 end-page: 941 ident: CR53 article-title: Competing aggregation pathways for monoclonal antibodies publication-title: FEBS Lett doi: 10.1016/j.febslet.2014.01.051 contributor: fullname: Roberts – volume: 7 start-page: 84 issue: 1 year: 2015 end-page: 95 ident: CR8 article-title: Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life publication-title: MAbs doi: 10.4161/19420862.2014.985494 contributor: fullname: Weis – volume: 241 start-page: 3 year: 2014 end-page: 17 ident: CR36 article-title: Chemical exchange in biomacromolecules: past, present, and future publication-title: J Magn Reson doi: 10.1016/j.jmr.2014.01.008 contributor: fullname: Palmer – volume: 31 start-page: 1189 issue: 10 year: 1991 end-page: 1204 ident: CR32 article-title: Conformational analysis of a IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulations publication-title: Biopolymers doi: 10.1002/bip.360311007 contributor: fullname: Huber – volume: 11 start-page: 1869 year: 2014 end-page: 1879 ident: CR49 article-title: Predicting protein aggregation during storage in lyophilized solids using solid state amide hydrogen/deuterium exchange with mass spectrometric analysis (ssHDX-MS) publication-title: Mol Pharm doi: 10.1021/mp500005v contributor: fullname: Topp – volume: 101 start-page: 1678 issue: 5 year: 2012 end-page: 1687 ident: CR28 article-title: Aggregation and pH–temperature phase behavior for aggregates of an IgG2 antibody publication-title: J Pharm Sci doi: 10.1002/jps.23056 contributor: fullname: Roberts – volume: 32 start-page: 372 issue: 7 year: 2014 end-page: 380 ident: CR54 article-title: Therapeutic protein aggregation: mechanisms, design, and control publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2014.05.005 contributor: fullname: Roberts – volume: 28 start-page: 8588 issue: 21 year: 1989 end-page: 8596 ident: CR27 article-title: A simple model for proteins with interacting domains. Applications to scanning calorimetry data publication-title: Biochemistry doi: 10.1021/bi00447a048 contributor: fullname: Mas – volume: 286 start-page: 1421 issue: 5 year: 1999 end-page: 1447 ident: CR34 article-title: The fab and fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling publication-title: J Mol Biol doi: 10.1006/jmbi.1998.2556 contributor: fullname: Perkins – volume: 48 start-page: 119 issue: 1 year: 2008 end-page: 127 ident: CR51 article-title: Thermostability of salt bridges versus hydrophobic interactions in proteins probed by statistical potentials publication-title: J Chem Inf Model doi: 10.1021/ci700237g contributor: fullname: Dehouck – volume: 12 start-page: 1005 year: 2015 ident: CR64 article-title: Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies publication-title: Mol Pharm doi: 10.1021/mp400666b contributor: fullname: Lantz – volume: 106 start-page: 1508 issue: 6 year: 2017 end-page: 1518 ident: CR65 article-title: Correlating the effects of antimicrobial preservatives on conformational stability, aggregation propensity, and backbone flexibility of an IgG1 mAb publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.02.007 contributor: fullname: Volkin – volume: 385 start-page: 787 issue: 6619 year: 1997 ident: CR56 article-title: Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis publication-title: Nature doi: 10.1038/385787a0 contributor: fullname: Robinson – volume: 5 start-page: 219 issue: 2 year: 2013 end-page: 228 ident: CR14 article-title: Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG publication-title: Mabs doi: 10.4161/mabs.23532 contributor: fullname: Parren – volume: 355 start-page: 751 issue: 3 year: 2007 end-page: 757 ident: CR24 article-title: A broad range of fab stabilities within a host of therapeutic IgGs publication-title: Biochemical and biophysical research communications, 2007 doi: 10.1016/j.bbrc.2007.02.042 contributor: fullname: Demarest – volume: 87 start-page: 3556 issue: 7 year: 2015 end-page: 3561 ident: CR20 article-title: Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance publication-title: Anal Chem doi: 10.1021/ac504804m contributor: fullname: Marino – volume: 328 start-page: 98 year: 2010 end-page: 102 ident: CR45 article-title: Dynamic regulation of archaeal proteasome gate opening as studied by TROSY NMR publication-title: Science doi: 10.1126/science.1184991 contributor: fullname: Kay – volume: 9 start-page: 257 year: 2015 end-page: 260 ident: CR44 article-title: Backbone 1 H, 13 C, and 15 N resonance assignments of the fc fragment of human immunoglobulin G glycoprotein publication-title: Biomolecular NMR assignments doi: 10.1007/s12104-014-9586-7 contributor: fullname: Kato – volume: 312 start-page: 224 year: 2006 end-page: 228 ident: CR42 article-title: New tools provide new insights in NMR studies of protein dynamics publication-title: Science doi: 10.1126/science.1124964 contributor: fullname: Kay – volume: 102 start-page: 2136 issue: 7 year: 2013 end-page: 2151 ident: CR18 article-title: Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry publication-title: J Pharm Sci doi: 10.1002/jps.23543 contributor: fullname: Volkin – volume: 107 start-page: 559 year: 2018 end-page: 570 ident: CR60 article-title: The use of a GroEL-BLI biosensor to rapidly assess preaggregate populations for antibody solutions exhibiting different stability profiles publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.10.010 contributor: fullname: Middaugh – volume: 140 start-page: 4774 issue: 14 year: 2018 end-page: 4777 ident: CR43 article-title: Investigating the dynamics of destabilized nucleosomes using methyl-TROSY NMR publication-title: J Am Chem Soc doi: 10.1021/jacs.8b00931 contributor: fullname: Kay – volume: 79 start-page: 2150 issue: 4 year: 2000 end-page: 2154 ident: CR30 article-title: The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F ab and F c fragments publication-title: Biophys J doi: 10.1016/S0006-3495(00)76462-9 contributor: fullname: van Amerongen – volume: 134 start-page: 6365 year: 2012 end-page: 6374 ident: CR35 article-title: Interpreting protein structural dynamics from NMR chemical shifts publication-title: J Am Chem Soc doi: 10.1021/ja300265w contributor: fullname: Palmer – volume: 3 start-page: 517 year: 1982 end-page: 521 ident: CR26 article-title: A thermodynamic study of cooperative structures in rabbit immunoglobulin G publication-title: FEBS J contributor: fullname: Privalov – volume: 129 start-page: 11300 issue: 37 year: 2007 end-page: 11301 ident: CR61 article-title: A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor publication-title: J Am Chem Soc doi: 10.1021/ja072157y contributor: fullname: Raleigh – volume: 10 start-page: 345 issue: 5 year: 2010 end-page: 352 ident: CR1 article-title: Thierry Wurch, Christian Bailly, and Nathalie Corvaia, Strategies and challenges for the next generation of therapeutic antibodies publication-title: Nat Rev Immunol doi: 10.1038/nri2747 contributor: fullname: Beck – volume: 22 start-page: 1542 issue: 11 year: 2013 end-page: 1551 ident: CR50 article-title: Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress publication-title: Protein Sci doi: 10.1002/pro.2340 contributor: fullname: Tsumoto – volume: 86 start-page: 3468 issue: 7 year: 2014 end-page: 3475 ident: CR15 article-title: Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling publication-title: Anal Chem doi: 10.1021/ac404130a contributor: fullname: Liu – volume: 89 start-page: 11839 issue: 21 year: 2017 ident: CR21 article-title: Multivariate analysis of two-dimensional 1H, 13C methyl NMR spectra of monoclonal antibody therapeutics to facilitate assessment of higher order structure publication-title: Anal Chem doi: 10.1021/acs.analchem.7b03571 contributor: fullname: Marino – volume: 194 start-page: 5497 year: 2015 end-page: 5508 ident: CR4 article-title: Fc engineering of human IgG1 for altered binding to the neonatal fc receptor affects fc effector functions publication-title: J Immunol doi: 10.4049/jimmunol.1401218 contributor: fullname: Grevys – volume: 103 start-page: 445 issue: 2 year: 2014 end-page: 455 ident: CR6 article-title: Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody publication-title: J Pharm Sci doi: 10.1002/jps.23827 contributor: fullname: Friess – volume: 33 start-page: 462 issue: 2 year: 2016 end-page: 475 ident: CR22 article-title: 2D 1 H N, 15 N correlated NMR methods at natural abundance for obtaining structural maps and statistical comparability of monoclonal antibodies publication-title: Pharm Res doi: 10.1007/s11095-015-1802-3 contributor: fullname: Marino – volume: 136 start-page: 311 issue: 2 year: 1981 end-page: 315 ident: CR58 article-title: α-Lactalbumin: compact state with fluctuating tertiary structure? publication-title: FEBS Lett doi: 10.1016/0014-5793(81)80642-4 contributor: fullname: Ptitsyn – volume: 97 start-page: 8340 issue: 15 year: 2000 end-page: 8345 ident: CR59 article-title: NMR structures of three single-residue variants of the human prion protein publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.97.15.8340 contributor: fullname: Wüthrich – volume: 155 start-page: 63 issue: 1 year: 2013 end-page: 71 ident: CR63 article-title: Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals publication-title: The Journal of Biochemistry doi: 10.1093/jb/mvt095 contributor: fullname: Arisaka – volume: 9 start-page: 767 issue: 10 year: 2010 end-page: 774 ident: CR2 article-title: Development trends for human monoclonal antibody therapeutics publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3229 contributor: fullname: Reichert – volume: 6 start-page: 32201 year: 2016 ident: CR23 article-title: Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies publication-title: Sci Rep doi: 10.1038/srep32201 contributor: fullname: Plavec – volume: 110 start-page: 12867 issue: 32 year: 2013 end-page: 12874 ident: CR19 article-title: NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers. NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1305688110 contributor: fullname: Kay – volume: 56 start-page: 131 issue: 1 year: 2013 end-page: 139 ident: CR31 article-title: IgG2 fc structure and the dynamic features of the IgG CH 2–CH 3 interface publication-title: Mol Immunol doi: 10.1016/j.molimm.2013.03.018 contributor: fullname: Gilliland – ident: CR3 – volume: 112 start-page: 326 issue: 4 year: 2011 end-page: 332 ident: CR7 article-title: Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition publication-title: J Biosci Bioeng doi: 10.1016/j.jbiosc.2011.06.017 contributor: fullname: Fukui – volume: 78 start-page: 394 issue: 1 year: 2000 end-page: 404 ident: CR11 article-title: The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein publication-title: Biophysical Journal doi: 10.1016/S0006-3495(00)76602-1 contributor: fullname: Norde – volume: 106 start-page: 3486 year: 2017 end-page: 3498 ident: CR29 article-title: Effect of Polysorbate 20 and Polysorbate 80 on the higher-order structure of a monoclonal antibody and its fab and fc fragments probed using 2D nuclear magnetic resonance spectroscopy publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.08.011 contributor: fullname: Mallela – ident: CR52 – volume: 98 start-page: 3013 issue: 9 year: 2009 end-page: 3030 ident: CR55 article-title: Elucidation of two major aggregation pathways in an IgG2 antibody publication-title: J Pharm Sci doi: 10.1002/jps.21514 contributor: fullname: Jacob – volume: 104 start-page: 4546 year: 1982 end-page: 4559 ident: CR38 article-title: Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity publication-title: J Am Chem Soc doi: 10.1021/ja00381a009 contributor: fullname: Szabo – volume: 424 start-page: 805 issue: 6950 year: 2003 ident: CR62 article-title: Rationalization of the effects of mutations on peptide and protein aggregation rates publication-title: Nature doi: 10.1038/nature01891 contributor: fullname: Dobson – volume: 20 start-page: 6842 issue: 24 year: 1981 end-page: 6852 ident: CR33 article-title: Segmental flexibility of immunoglobulin G antibody molecules in solution: a new interpretation publication-title: Biochemistry doi: 10.1021/bi00527a016 contributor: fullname: Schumaker – volume: 325 start-page: 979 issue: 5 year: 2003 end-page: 989 ident: CR39 article-title: Structural analysis of human IgG-fc glycoforms reveals a correlation between glycosylation and structural integrity publication-title: J Mol Biol doi: 10.1016/S0022-2836(02)01250-0 contributor: fullname: Sondermann – volume: 52 start-page: 3376 issue: 19 year: 2013 end-page: 3389 ident: CR17 article-title: Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody publication-title: Biochemistry doi: 10.1021/bi400232p contributor: fullname: Weis – volume: 6 start-page: 38 issue: 1 year: 2010 end-page: 44 ident: CR40 article-title: Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies publication-title: Biotechnology Journal doi: 10.1002/biot.201000091 contributor: fullname: Trout – volume: 9 start-page: 696 year: 2012 end-page: 707 ident: CR5 article-title: Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies publication-title: Mol Pharm doi: 10.1021/mp200404c contributor: fullname: He – volume: 97 start-page: 3494 issue: 9 year: 2008 end-page: 3517 ident: CR10 article-title: The complex inter-relationships between protein flexibility and stability publication-title: J Pharm Sci doi: 10.1002/jps.21269 contributor: fullname: Middaugh – volume: 34 start-page: 601 year: 2009 end-page: 611 ident: CR37 article-title: Observing biological dynamics at atomic resolution using NMR publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2009.07.004 contributor: fullname: Kay – volume: 56 start-page: 131 year: 2013 end-page: 139 ident: CR46 article-title: IgG2 fc structure and the dynamic features of the IgG CH2–CH3 interface publication-title: Mol Immunol doi: 10.1016/j.molimm.2013.03.018 contributor: fullname: Gilliland – volume: 46 start-page: 1750 issue: 8 year: 2009 end-page: 1755 ident: CR9 article-title: Structural characterization of a human fc fragment engineered for extended serum half-life publication-title: Mol Immunol doi: 10.1016/j.molimm.2009.01.026 contributor: fullname: Dall’Acqua – volume: 19 start-page: 1191 issue: 6 year: 2010 end-page: 1204 ident: CR12 article-title: The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies publication-title: Protein Sci doi: 10.1002/pro.396 contributor: fullname: Latypov – volume: 104 start-page: 4546 year: 1982 ident: 2500_CR38 publication-title: J Am Chem Soc doi: 10.1021/ja00381a009 contributor: fullname: G Lipari – volume: 6 start-page: 32201 year: 2016 ident: 2500_CR23 publication-title: Sci Rep doi: 10.1038/srep32201 contributor: fullname: B Japelj – volume: 6 start-page: 38 issue: 1 year: 2010 ident: 2500_CR40 publication-title: Biotechnology Journal doi: 10.1002/biot.201000091 contributor: fullname: Veysel Kayser – volume: 56 start-page: 131 year: 2013 ident: 2500_CR46 publication-title: Mol Immunol doi: 10.1016/j.molimm.2013.03.018 contributor: fullname: A Teplyakov – ident: 2500_CR52 doi: 10.1016/j.str.2018.03.017 – volume: 106 start-page: 1508 issue: 6 year: 2017 ident: 2500_CR65 publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.02.007 contributor: fullname: J Arora – volume: 31 start-page: 1189 issue: 10 year: 1991 ident: 2500_CR32 publication-title: Biopolymers doi: 10.1002/bip.360311007 contributor: fullname: H Kessler – volume: 194 start-page: 5497 year: 2015 ident: 2500_CR4 publication-title: J Immunol doi: 10.4049/jimmunol.1401218 contributor: fullname: A Grevys – volume: 286 start-page: 1421 issue: 5 year: 1999 ident: 2500_CR34 publication-title: J Mol Biol doi: 10.1006/jmbi.1998.2556 contributor: fullname: MK Boehm – volume: 47 start-page: 5088 year: 2008 ident: 2500_CR41 publication-title: Biochemistry doi: 10.1021/bi702238b contributor: fullname: D Liu – volume: 312 start-page: 224 year: 2006 ident: 2500_CR42 publication-title: Science doi: 10.1126/science.1124964 contributor: fullname: A Mittermaier – volume: 48 start-page: 119 issue: 1 year: 2008 ident: 2500_CR51 publication-title: J Chem Inf Model doi: 10.1021/ci700237g contributor: fullname: B Folch – volume: 136 start-page: 311 issue: 2 year: 1981 ident: 2500_CR58 publication-title: FEBS Lett doi: 10.1016/0014-5793(81)80642-4 contributor: fullname: DA Dolgikh – volume: 241 start-page: 3 year: 2014 ident: 2500_CR36 publication-title: J Magn Reson doi: 10.1016/j.jmr.2014.01.008 contributor: fullname: AG Palmer III – volume: 19 start-page: 1191 issue: 6 year: 2010 ident: 2500_CR12 publication-title: Protein Sci doi: 10.1002/pro.396 contributor: fullname: SLH Chen – volume: 106 start-page: 3486 year: 2017 ident: 2500_CR29 publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.08.011 contributor: fullname: SM Singh – volume: 588 start-page: 936 issue: 6 year: 2014 ident: 2500_CR53 publication-title: FEBS Lett doi: 10.1016/j.febslet.2014.01.051 contributor: fullname: H Wu – volume: 355 start-page: 751 issue: 3 year: 2007 ident: 2500_CR24 publication-title: Biochemical and biophysical research communications, 2007 doi: 10.1016/j.bbrc.2007.02.042 contributor: fullname: E Garber – volume: 3 start-page: 517 year: 1982 ident: 2500_CR26 publication-title: FEBS J contributor: fullname: VM Tischenko – volume: 103 start-page: 445 issue: 2 year: 2014 ident: 2500_CR6 publication-title: J Pharm Sci doi: 10.1002/jps.23827 contributor: fullname: T Menzen – volume: 19 start-page: 826 issue: 4 year: 2010 ident: 2500_CR16 publication-title: Protein Sci doi: 10.1002/pro.362 contributor: fullname: W Burkitt – volume: 101 start-page: 1678 issue: 5 year: 2012 ident: 2500_CR28 publication-title: J Pharm Sci doi: 10.1002/jps.23056 contributor: fullname: E Sahin – volume: 89 start-page: 11839 issue: 21 year: 2017 ident: 2500_CR21 publication-title: Anal Chem doi: 10.1021/acs.analchem.7b03571 contributor: fullname: LW Arbogast – volume: 20 start-page: 6842 issue: 24 year: 1981 ident: 2500_CR33 publication-title: Biochemistry doi: 10.1021/bi00527a016 contributor: fullname: DC Hanson – volume: 42 start-page: 2363 year: 2003 ident: 2500_CR57 publication-title: Biochemistry doi: 10.1021/bi026364g contributor: fullname: A Kjellsson – volume: 87 start-page: 3556 issue: 7 year: 2015 ident: 2500_CR20 publication-title: Anal Chem doi: 10.1021/ac504804m contributor: fullname: LW Arbogast – volume: 22 start-page: 1542 issue: 11 year: 2013 ident: 2500_CR50 publication-title: Protein Sci doi: 10.1002/pro.2340 contributor: fullname: T Ito – volume: 78 start-page: 394 issue: 1 year: 2000 ident: 2500_CR11 publication-title: Biophysical Journal doi: 10.1016/S0006-3495(00)76602-1 contributor: fullname: Arnoldus W.P. Vermeer – volume: 52 start-page: 3376 issue: 19 year: 2013 ident: 2500_CR17 publication-title: Biochemistry doi: 10.1021/bi400232p contributor: fullname: R Majumdar – volume: 56 start-page: 131 issue: 1 year: 2013 ident: 2500_CR31 publication-title: Mol Immunol doi: 10.1016/j.molimm.2013.03.018 contributor: fullname: A Teplyakov – volume: 107 start-page: 559 year: 2018 ident: 2500_CR60 publication-title: J Pharm Sci doi: 10.1016/j.xphs.2017.10.010 contributor: fullname: SE Pace – volume: 97 start-page: 8340 issue: 15 year: 2000 ident: 2500_CR59 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.97.15.8340 contributor: fullname: L Calzolai – volume: 10 start-page: 345 issue: 5 year: 2010 ident: 2500_CR1 publication-title: Nat Rev Immunol doi: 10.1038/nri2747 contributor: fullname: A Beck – volume: 98 start-page: 3013 issue: 9 year: 2009 ident: 2500_CR55 publication-title: J Pharm Sci doi: 10.1002/jps.21514 contributor: fullname: N Buren Van – volume: 129 start-page: 11300 issue: 37 year: 2007 ident: 2500_CR61 publication-title: J Am Chem Soc doi: 10.1021/ja072157y contributor: fullname: A Abedini – volume: 81 start-page: 2644 issue: 7 year: 2009 ident: 2500_CR13 publication-title: Anal Chem doi: 10.1021/ac802575y contributor: fullname: D Houde – volume: 9 start-page: 257 year: 2015 ident: 2500_CR44 publication-title: Biomolecular NMR assignments doi: 10.1007/s12104-014-9586-7 contributor: fullname: H Yagi – volume: 328 start-page: 98 year: 2010 ident: 2500_CR45 publication-title: Science doi: 10.1126/science.1184991 contributor: fullname: TL Religa – volume: 12 start-page: 1005 year: 2015 ident: 2500_CR64 publication-title: Mol Pharm doi: 10.1021/mp400666b contributor: fullname: ML Brader – ident: 2500_CR3 doi: 10.1080/19420862.2016.1269580 – volume: 325 start-page: 979 issue: 5 year: 2003 ident: 2500_CR39 publication-title: J Mol Biol doi: 10.1016/S0022-2836(02)01250-0 contributor: fullname: S Krapp – volume: 33 start-page: 462 issue: 2 year: 2016 ident: 2500_CR22 publication-title: Pharm Res doi: 10.1007/s11095-015-1802-3 contributor: fullname: LW Arbogast – volume: 34 start-page: 601 year: 2009 ident: 2500_CR37 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2009.07.004 contributor: fullname: AK Mittermaier – volume: 40 start-page: 2743 issue: 9 year: 2001 ident: 2500_CR48 publication-title: Biochemistry doi: 10.1021/bi002898a contributor: fullname: JH Viles – volume: 112 start-page: 326 issue: 4 year: 2011 ident: 2500_CR7 publication-title: J Biosci Bioeng doi: 10.1016/j.jbiosc.2011.06.017 contributor: fullname: H Nishi – volume: 97 start-page: 3494 issue: 9 year: 2008 ident: 2500_CR10 publication-title: J Pharm Sci doi: 10.1002/jps.21269 contributor: fullname: TJ Kamerzell – volume: 28 start-page: 8588 issue: 21 year: 1989 ident: 2500_CR27 publication-title: Biochemistry doi: 10.1021/bi00447a048 contributor: fullname: JF Brandts – volume: 102 start-page: 2136 issue: 7 year: 2013 ident: 2500_CR18 publication-title: J Pharm Sci doi: 10.1002/jps.23543 contributor: fullname: P Manikwar – volume: 12 start-page: 601 issue: 34 year: 2009 ident: 2500_CR47 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2009.07.004 contributor: fullname: AK Mittermaier – volume: 9 start-page: 767 issue: 10 year: 2010 ident: 2500_CR2 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3229 contributor: fullname: AL Nelson – volume: 385 start-page: 787 issue: 6619 year: 1997 ident: 2500_CR56 publication-title: Nature doi: 10.1038/385787a0 contributor: fullname: DR Booth – volume: 9 start-page: 696 year: 2012 ident: 2500_CR5 publication-title: Mol Pharm doi: 10.1021/mp200404c contributor: fullname: HS Samra – volume: 110 start-page: 12867 issue: 32 year: 2013 ident: 2500_CR19 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1305688110 contributor: fullname: A Sekhar – volume: 155 start-page: 63 issue: 1 year: 2013 ident: 2500_CR63 publication-title: The Journal of Biochemistry doi: 10.1093/jb/mvt095 contributor: fullname: T Iwura – volume: 140 start-page: 4774 issue: 14 year: 2018 ident: 2500_CR43 publication-title: J Am Chem Soc doi: 10.1021/jacs.8b00931 contributor: fullname: JL Kitevski-LeBlanc – volume: 424 start-page: 805 issue: 6950 year: 2003 ident: 2500_CR62 publication-title: Nature doi: 10.1038/nature01891 contributor: fullname: F Chiti – volume: 11 start-page: 1869 year: 2014 ident: 2500_CR49 publication-title: Mol Pharm doi: 10.1021/mp500005v contributor: fullname: BS Moorthy – volume: 46 start-page: 1750 issue: 8 year: 2009 ident: 2500_CR9 publication-title: Mol Immunol doi: 10.1016/j.molimm.2009.01.026 contributor: fullname: V Oganesyan – volume: 32 start-page: 372 issue: 7 year: 2014 ident: 2500_CR54 publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2014.05.005 contributor: fullname: CJ Roberts – volume: 97 start-page: 1414 issue: 4 year: 2008 ident: 2500_CR25 publication-title: J Pharm Sci doi: 10.1002/jps.21104 contributor: fullname: RM Ionescu – volume: 134 start-page: 6365 year: 2012 ident: 2500_CR35 publication-title: J Am Chem Soc doi: 10.1021/ja300265w contributor: fullname: P Robustelli – volume: 5 start-page: 219 issue: 2 year: 2013 ident: 2500_CR14 publication-title: Mabs doi: 10.4161/mabs.23532 contributor: fullname: RJ Rose – volume: 7 start-page: 84 issue: 1 year: 2015 ident: 2500_CR8 publication-title: MAbs doi: 10.4161/19420862.2014.985494 contributor: fullname: R Majumdar – volume: 86 start-page: 3468 issue: 7 year: 2014 ident: 2500_CR15 publication-title: Anal Chem doi: 10.1021/ac404130a contributor: fullname: A Zhang – volume: 79 start-page: 2150 issue: 4 year: 2000 ident: 2500_CR30 publication-title: Biophys J doi: 10.1016/S0006-3495(00)76462-9 contributor: fullname: AW Vermeer |
SSID | ssj0008194 |
Score | 2.3717318 |
Snippet | Purpose
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common... Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach... Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common... PurposeFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common... PURPOSEFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 220 |
SubjectTerms | Amino acids Analysis Biochemistry Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine DNA fingerprinting Fc receptors Fingerprinting Fragmentation Fragments Glycosylation Health aspects Heat measurement Homology Investigations Medical Law Melt temperature Monoclonal antibodies Mutation NMR Nuclear magnetic resonance Pharmacology/Toxicology Pharmacy Proteins Research Paper Shelf life Storage stability |
SummonAdditionalLinks | – databaseName: Proquest Health & Medical Complete dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7S9JJL6Sut27SoUBJII2pZWls-laXpEgIte0hgexKWLC0LiZ1knUP-fWf8WHcD7c2gpzWj0XyahwA-e-l80DrlNlGSqzQo_Mokt66wthSZtoGikX_-Ss8u1flisugv3Na9W-UgE1tBXdaO7si_IlBJKLOhyr_d3HJ6NYqsq_0TGk_gKZam5NKVLTaAi067Nn0UtsJdr8Rg1WxD50RMsckC-WQSx1xvnUuPpfNfx9Mje2l7DM2ew7Nef2TTjuAvYMdXL-Fw3iWgfjhhF2M81fqEHbL5mJr64RX8nlPapWrJKNBvCFvE7k4H7wxWBzZz7LS-LlbVmq0qNl0iIl-2FTm2rjxDMVC7q7bdtGpWtiZHxNdwOftx8f2M948rcIdKT8NxIX0gUIqSF0GdLLVQZYHgEIlUeERlpctIHxHahzwtxKRwwQelsqATV9pE7sNuhYO-BZYhaHNWBC_igOVZrmOby9IpqbTNbYjgeFhac9Pl0DBjtmSig0E6GKKD0REc0eIb2l_NXeGKPkwAh6JMVWaakRGb7K0RHGzVxH3htosH8pl-X67NyEURfNoUU0vyNat8fd_VQSUHcWEEbzqyb6YtCYLJiYjgy8AHY-f__Kd3_5_Ke9hLiBHbCMcD2G3u7v0HVHUa-7Hl5z82dPlK priority: 102 providerName: ProQuest |
Title | Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies |
URI | https://link.springer.com/article/10.1007/s11095-018-2500-8 https://www.ncbi.nlm.nih.gov/pubmed/30255351 https://www.proquest.com/docview/2112047249 https://search.proquest.com/docview/2112613259 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_t44UXxDeBURkJDQkWFMdO7TwG1jKBmCq0St1TFDt2VQ0StGYP---5S5qGTvDAUyL5bCc-n32_nO8XgDdOWOe1HocmliKUYy_xTonQ2MKYkittPGUjfzsfn83ll0Wy2IN4--miuvrQRyTbhXrIdeMRJRNzVGwSRaHeh8OE2NBwDs_jbLv64g7XUkapWKKlS95HMv_WxM5edHdF_mNLuhMjbbee6QO4v_EZWdYp-SHsueoRHM860unbE3Yx5FCtT9gxmw101LeP4XJGVEvVklFyX5-qiM2d9icyWO3Z1LLT-mexqtZsVbFsiSh82QqGWLtyDE2_tj_aelnVrExNhw-fwHw6ufh0Fm5-qBBadHSaEKGW8wREcbVFICdKzWVZICBExRQOkVhpFfkgXDufjgueFNY7L6XyOralicVTOKiw0-fAFAI1a7h3PPJYrlIdmVSUVgqpTWp8AO_6oc1_dbwZ-cCQTHrIUQ856SHXAbylwc_Jpprrwhab1ADsitip8kxR4JpirAEc7UiiLdjd4l59-cYW1zlC3Jg4MWUawOttMdWk82WVq286GXRsEAsG8KxT-_axBcEukfAA3vfzYGj8n-_04r-kX8K9mOZlm-R4BAfN9Y17hd5OY0awrxZqBIfZ58uvE7x-nJzPvo_aSf8bjSv5hA |
link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,41093,41535,42162,42604,43322,43817,52123,52246,74073,74630 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BOcAF8SZQwEioSFCrcezdOCe0oqwWaKs9bKXlZMWOvVoJktJND_33zOSxYSvBLZIfSTzj8Xwez2eAd146H7Qec5soydU4KHxKJbcut7YQqbaBspFPz8azc_VtOVp2G26b7lhlbxMbQ11UjvbIjxCoJMRsqLJPF7853RpF0dXuCo3bcId4uOgGg3S5BVy02jX0UdgKZ70SfVSzSZ0TMeUmC9STURxzvbMu3bTOfy1PN-KlzTI0fQD3O_-RTVqBP4RbvnwEB_OWgPr6kC2GfKrNITtg84Ga-vox_JgT7VK5YpTo16ctYnfH_ekMVgU2dey4-pWvyw1bl2yyQkS-aipybF16hmagcj-bdpOyXtuKDiI-gfPpl8XnGe8uV-AOnZ6a40D6QKAULS-COllooYocwSEKKfeIygqXkj8itA_ZOBej3AUflEqDTlxhE_kU9kp86XNgKYI2Z0XwIg5YnmY6tpksnJJK28yGCD70Q2suWg4NM7AlkxwMysGQHIyO4D0NvqH5VV_mLu_SBPBVxFRlJikFsSneGsH-Tk2cF263uBef6eblxgxaFMHbbTG1pLNmpa-u2jro5CAujOBZK_btZ0uCYHIkIvjY68HQ-T__6cX_P-UN3J0tTk_Mydez7y_hXkJK2WQ77sNefXnlX6HbU9vXjW7_Af_r_DE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB7BVkK8IG5SChgJFQkaNY69ifOEFrarcq1WqJXKkxU79molSNpu-tB_z0yODVsJ3iL5SjzjmfkyhwHeOGGdVyoJTSxFKBMv8SkVobG5MQVPlfGUjfx9nhyfyi9n47Mu_mndhVX2MrER1EVl6R_5IQKVmCobyuzQd2ERi-nsw_lFSDdIkae1u07jNuykMhHRCHY-Hs0XPzZyGXVfU0wK50AZIHnv42wS6XhEmcocuWYcRaHa0lI3ZfVfyuqG97RRSrP7cK-zJtmkJf8DuOXKh7C_aMtRXx-wkyG7an3A9tliKFR9_Qh-LqgIU7lklPbXJzHidNM-VoNVns0sm1a_81W5ZquSTZaIz5dNxxBHl46hUKjsr2bcpKxXpqKwxMdwOjs6-XQcdlcthBZNoDrEbXWeICrKYYR4olBcFjlCRSRZ7hCjFTYl64Qr57Mk5-PceuelTL2KbWFi8QRGJS76DFiKEM4a7h2PPLanmYpMJgorhVQmMz6Ad_3W6vO2ooYeaicTHTTSQRMdtArgLW2-ptNWX-Y275IGcCmqW6UnKbm0yfsawN5WTzwldru5J5_uTulaDzwVwOtNM42kyLPSVVdtHzR5ECUG8LQl--a1BQEyMeYBvO_5YJj8n9-0-_9XeQV3kLH1t8_zr8_hbkw82aQ-7sGovrxyL9AGqs3Ljrn_AG59Ad0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Probing+Conformational+Diversity+of+Fc+Domains+in+Aggregation-Prone+Monoclonal+Antibodies&rft.jtitle=Pharmaceutical+research&rft.au=Majumder%2C+Subhabrata&rft.au=Jones%2C+Michael+T.&rft.au=Kimmel%2C+Michael&rft.au=Alphonse+Ignatius%2C+Arun&rft.date=2018-11-01&rft.pub=Springer+US&rft.issn=0724-8741&rft.eissn=1573-904X&rft.volume=35&rft.issue=11&rft_id=info:doi/10.1007%2Fs11095-018-2500-8&rft.externalDocID=10_1007_s11095_018_2500_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0724-8741&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0724-8741&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0724-8741&client=summon |